Ledger.Open graph →
SEC Form D · Amendment · filed May 9, 2024

OverT Bio, Inc

Offering
$17.0M
Sold
$16.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Sara Choi · New York, NYDirectorNeville Sanjana · New York, NYDirectorVasudev Bailey · New York, NYDirectorMateusz Legut · New York, NYExec · DirectorAndy T. Holloway · BUTTE, MTDirectorDavid L. Vitale · Chicago, ILDirectorQuinton T. Hennigh · BUTTE, MTDirectorSteve T. Durbin · BUTTE, MTExec · DirectorTimothy P. Faenza · New York, NYDirectorScott Huff · Wilmington, DEDirectorKyle V. Nguyen · Brooklyn, NYExec · DirectorJames Kintner · Seattle, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗